What's new

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 27, Status: Authorised

Apr 10, 2025 - 14:00
 0
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Da...

Next Article

Oxford PV, Trinasolar enter perovskite-silicon tandem patent licensing agreement

Related Posts

Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya vaccine (recombinant, adsorbed), Date of authorisation: 28/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Feraccru, ferric maltol, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0503/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan), clopidogrel,acetylsalicylic acid, Date of authorisation: 09/01/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0